SEC Tracker
Get the app

Qualigen Therapeutics FFR

Qualigen Therapeutics: signs a material agreement, reports a change in control and 2 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
  • Signs a material agreement (1.01)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Qualigen Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6199 and related industry codes: the same peer list as the financial tables.

  1. SkyAI SKYA public float $6M, Jun 30, 2025
  2. Crisp Momentum CRSF public float $6M, Jan 31, 2025, over 18 months old
  3. Pineapple Financial PAPL public float $5M, Aug 31, 2025
  4. Solana HSDT public float $6M, Jun 30, 2025
  5. Marvion MVNC public float $5M, Jun 30, 2025